"Proteoglycans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins which have a very high polysaccharide content.
| Descriptor ID |
D011509
|
| MeSH Number(s) |
D09.698.735 D12.776.395.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteoglycans".
Below are MeSH descriptors whose meaning is more specific than "Proteoglycans".
This graph shows the total number of publications written about "Proteoglycans" by people in this website by year, and whether "Proteoglycans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 2 | 5 |
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 4 | 6 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 3 | 4 |
| 2000 | 2 | 9 | 11 |
| 2001 | 3 | 5 | 8 |
| 2002 | 0 | 10 | 10 |
| 2003 | 2 | 7 | 9 |
| 2004 | 1 | 15 | 16 |
| 2005 | 1 | 8 | 9 |
| 2006 | 3 | 7 | 10 |
| 2007 | 2 | 9 | 11 |
| 2008 | 6 | 7 | 13 |
| 2009 | 3 | 1 | 4 |
| 2010 | 3 | 2 | 5 |
| 2011 | 0 | 5 | 5 |
| 2012 | 2 | 2 | 4 |
| 2013 | 2 | 3 | 5 |
| 2014 | 1 | 5 | 6 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 3 | 4 |
| 2018 | 2 | 2 | 4 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 2 | 3 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proteoglycans" by people in Profiles.
-
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 Nov; 31(11-12):587-593.
-
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis. Arthritis Res Ther. 2023 04 11; 25(1):57.
-
Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation. Nat Commun. 2023 03 27; 14(1):1694.
-
APOL1 Kidney Risk Variants and Proteomics. Clin J Am Soc Nephrol. 2022 05; 17(5):684-692.
-
Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma. Pathol Oncol Res. 2022; 28:1610293.
-
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. J Natl Cancer Inst. 2022 02 07; 114(2):290-301.
-
miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGF?R3. J Invest Dermatol. 2022 07; 142(7):1956-1965.e2.
-
Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 11 01; 53(11):486-508.
-
A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma. Commun Biol. 2021 03 22; 4(1):383.
-
Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. J Infect. 2020 09; 81(3):443-451.